Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
GENERIC NAME: varenicline
BRAND NAME: Chantix
DRUG CLASS AND MECHANISM: Varenicline is an oral drug that is used to promote cessation of smoking. It competes with nicotine from cigarettes for binding to nicotine receptors in the brain. Although varenicline stimulates nicotine receptors like nicotine, it blocks the stronger stimulation by nicotine. Therefore, smokers do not experience the full effect of smoking while taking varenicline. The FDA approved varenicline in May 2006.
GENERIC AVAILABLE: No
PREPARATIONS: Capsules: 0.5 and 0.1 mg
STORAGE: Varenicline should be stored at room temperature, 15 to 30 C (59 to 86 F).
PRESCRIBED FOR: Varenicline is an aid for smoking cessation.
DOSING: The recommended dose is 0.5 mg daily for 3 days followed by 0.5 mg twice daily for 4 days, then 1 mg twice daily for the remainder of the treatment period. Duration of therapy is 12 weeks. If treatment is successful, an additional 12 weeks is recommended to increase the chance of long-term abstinence. Those who do not respond or return to smoking after treatment should be encouraged to try again.
DRUG INTERACTIONS: Administering varenicline with the nicotine patch may lead to additional adverse effects.
PREGNANCY: There are no adequate studies in pregnant women.
NURSING MOTHERS: It is not known whether varenicline is excreted in breast milk. Nursing mothers should consider discontinuing varenicline or breastfeeding because of the potential for adverse effects in the infant.
SIDE EFFECTS: The most common adverse effects of varenicline are nausea, sleep disturbance, constipation, flatulence, and vomiting. Headaches, abnormal dreams and taste disturbance also are frequent side effects of varenicline. Varenicline is not addictive and is not a controlled substance; however, some patients may experience irritability and sleep disturbance if varenicline is abruptly discontinued. Varenicline may worsen symptoms of underlying heart disease. Patients may experience psychiatric symptoms such as behavioral changes, agitation, depressed mood, and suicidal behavior during varenicline treatment. Patients should stop taking varenicline if psychiatric symptoms occur. Rare life threatening skin reactions and hypersensitivity reactions have been reported.
Reference: FDA Prescribing Information
Last Editorial Review: 7/18/2012
Report Problems to the Food and Drug Administration
Need help identifying pills and medications?
Back to Medications Index